Mallinckrodt plc

Track this case

Case overview

Case Number:

1:20-bk-12522

Court:

Delaware

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

September 13, 2021
Mallinckrodt Creditors Say Ch. 11 Plan Understates Revenues

Senior creditors of bankrupt drugmaker Mallinckrodt Corp. have objected to confirmation of its multibillion-dollar Chapter 11 plan, arguing that the company failed to take into account worldwide revenues from a breakthrough skin graft substitute recently approved by the Food and Drug Administration.
July 16, 2021
Bankruptcy Cases To Watch In The Second Half Of 2021

Though the pace of new bankruptcy cases slowed in the first half of 2021, the proceedings of large and complex cases continue to wind their way through the nation's insolvency courts. Here, Law360 gives a preview of what to expect for the remainder of 2021 in significant pending cases.
June 15, 2021
Mallinckrodt Ch. 11 Plan Disclosure Challenges Shot Down

A Delaware bankruptcy judge Tuesday heard and rejected multiple challenges to opioid maker Mallinckrodt PLC's proposed Chapter 11 disclosures, saying they contain sufficient information on topics ranging from payouts from states to disputed intercompany transfers.
June 14, 2021
Mallinckrodt Says Ch. 11 Disclosures Have Enough Info

Drugmaker Mallinckrodt PLC Monday defended the disclosure statement for its proposed Chapter 11 plan, telling a Delaware bankruptcy judge that it has provided creditors with all the information they need to vote on the plan.
May 26, 2021
Mallinckrodt Ch. 11 Trustee Hearing Set For Confirmation

A group of plaintiffs alleging claims against bankrupt pharmaceutical company Mallinckrodt PLC will have their motion seeking appointment of a Chapter 11 trustee in the case heard during the debtor's plan confirmation hearing, a Delaware judge ruled Wednesday.
May 21, 2021
Drug Industry Group Slams Mallinckrodt Ch. 11 Disclosures

A group of makers and distributors of Mallinckrodt PLC's opioids have asked a Delaware bankruptcy judge to reject the company's Chapter 11 plan disclosures for lack of clarity and because they would allow Mallinckrodt to pick and choose its contractual obligations.
May 20, 2021
Mallinckrodt's Ch. 11 Claim Deadline OK'd Over Opposition

A June 28 deadline for creditors of bankrupt pharmaceutical company Mallinckrodt to file proofs of claim against the company overcame objections from a group of plaintiffs alleging price-fixing damages Thursday, with a Delaware judge saying opposition to the debtor's proposed noticing procedures was unfounded.
May 18, 2021
Med Buyers Say Mallinckrodt Too Incompetent To Run Ch. 11

Drug buyers alleging bankrupt pharmaceutical company Mallinckrodt PLC overcharged for its Acthar Gel medication have again told a Delaware judge that a Chapter 11 trustee must take over the case, saying Mallinckrodt's leadership lacks the competence necessary to complete the reorganization.
April 13, 2021
Mallinckrodt Slams Bid To DQ Arnold & Porter In Its Ch. 11

Mallinckrodt PLC urged a Delaware bankruptcy judge Monday to reject a bid to disqualify Arnold & Porter from serving as special counsel in its Chapter 11, arguing certain litigants are attempting to have the firm booted based on "rank speculation and fanciful conspiracy theories."
April 05, 2021
Mallinckrodt Gets OK For Up To $35M In Exec Bonuses

A Delaware bankruptcy judge on Monday gave drugmaker Mallinckrodt PLC permission to give its top executives up to $35 million in performance-based bonuses, rejecting creditor arguments that the executives could be responsible for the company's legal troubles.